DLX2 and Hodgkins lymphoma: Interestingly, the Hodgkin lymphoma therapeutic target CD27 was expressed at lower level with TES1m rescue but more highly expressed in cells with TES2m rescue, suggesting that TES1 and TES2 signaling may jointly balance its expression.